SK144293A3 - Orally active antiviral compounds - Google Patents
Orally active antiviral compounds Download PDFInfo
- Publication number
- SK144293A3 SK144293A3 SK1442-93A SK144293A SK144293A3 SK 144293 A3 SK144293 A3 SK 144293A3 SK 144293 A SK144293 A SK 144293A SK 144293 A3 SK144293 A3 SK 144293A3
- Authority
- SK
- Slovakia
- Prior art keywords
- compound
- compounds
- alkyl
- formula
- compound according
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D213/28—Radicals substituted by singly-bound oxygen or sulphur atoms
- C07D213/30—Oxygen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C43/00—Ethers; Compounds having groups, groups or groups
- C07C43/02—Ethers
- C07C43/20—Ethers having an ether-oxygen atom bound to a carbon atom of a six-membered aromatic ring
- C07C43/225—Ethers having an ether-oxygen atom bound to a carbon atom of a six-membered aromatic ring containing halogen
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C43/00—Ethers; Compounds having groups, groups or groups
- C07C43/02—Ethers
- C07C43/20—Ethers having an ether-oxygen atom bound to a carbon atom of a six-membered aromatic ring
- C07C43/23—Ethers having an ether-oxygen atom bound to a carbon atom of a six-membered aromatic ring containing hydroxy or O-metal groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
- C07C69/76—Esters of carboxylic acids having a carboxyl group bound to a carbon atom of a six-membered aromatic ring
- C07C69/84—Esters of carboxylic acids having a carboxyl group bound to a carbon atom of a six-membered aromatic ring of monocyclic hydroxy carboxylic acids, the hydroxy groups and the carboxyl groups of which are bound to carbon atoms of a six-membered aromatic ring
- C07C69/92—Esters of carboxylic acids having a carboxyl group bound to a carbon atom of a six-membered aromatic ring of monocyclic hydroxy carboxylic acids, the hydroxy groups and the carboxyl groups of which are bound to carbon atoms of a six-membered aromatic ring with etherified hydroxyl groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
- C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
- C07D263/08—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D263/10—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
- C07D263/14—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms with radicals substituted by oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
- C07D307/04—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
- C07D307/10—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D307/12—Radicals substituted by oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
- C07D307/26—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D307/28—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
- C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D307/38—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D307/40—Radicals substituted by oxygen atoms
- C07D307/42—Singly bound oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
- C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
- C07D333/06—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
- C07D333/14—Radicals substituted by singly bound hetero atoms other than halogen
- C07D333/16—Radicals substituted by singly bound hetero atoms other than halogen by oxygen atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Communicable Diseases (AREA)
- Animal Behavior & Ethology (AREA)
- Oncology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Pyridine Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Cosmetics (AREA)
- Medicines Containing Plant Substances (AREA)
- Dental Preparations (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US71745191A | 1991-06-19 | 1991-06-19 | |
| PCT/US1992/004961 WO1992022520A1 (en) | 1991-06-19 | 1992-06-17 | Orally active antiviral compounds |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SK144293A3 true SK144293A3 (en) | 1994-06-08 |
Family
ID=24882086
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SK1442-93A SK144293A3 (en) | 1991-06-19 | 1992-06-17 | Orally active antiviral compounds |
Country Status (23)
| Country | Link |
|---|---|
| US (4) | US5559133A (es) |
| EP (2) | EP0519702A1 (es) |
| JP (1) | JP2625258B2 (es) |
| KR (1) | KR960004887B1 (es) |
| AT (1) | ATE182874T1 (es) |
| AU (1) | AU674657B2 (es) |
| CA (1) | CA2111854C (es) |
| CZ (1) | CZ279793A3 (es) |
| DE (1) | DE69229733T2 (es) |
| ES (1) | ES2134808T3 (es) |
| FI (1) | FI935690A (es) |
| IE (1) | IE921971A1 (es) |
| IL (1) | IL102241A0 (es) |
| MX (1) | MX9203068A (es) |
| MY (1) | MY107993A (es) |
| NZ (1) | NZ243180A (es) |
| OA (1) | OA09828A (es) |
| PL (1) | PL169699B1 (es) |
| SK (1) | SK144293A3 (es) |
| TW (1) | TW260658B (es) |
| WO (1) | WO1992022520A1 (es) |
| YU (1) | YU63392A (es) |
| ZA (1) | ZA924445B (es) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2625258B2 (ja) * | 1991-06-19 | 1997-07-02 | シェリング・コーポレーション | 経口活性抗ウィルス化合物 |
| CA2156916A1 (en) * | 1993-02-26 | 1994-09-01 | Edward J. Rozhon | Use of 2-chloro-1¬¬4-(2,6-dichlorophenoxy)methyl|-phenyl|methoxy|- 4-methoxy-benzene for the selective treatment of enteroviral infections in humans |
| DE69830751T2 (de) * | 1997-04-10 | 2006-05-18 | Pharmacia & Upjohn Co. Llc, Kalamazoo | Polyaromatische Verbindungen zur Behandlung von Herpes-Infektionen |
| AU6462500A (en) * | 1999-07-29 | 2001-02-19 | Patrick T. Prendergast | Dithiolthione compounds for the treatment of neurological disorders and for memory enhancement |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE2418571A1 (de) * | 1973-04-18 | 1974-11-14 | Ciba Geigy Ag | Phenyl-aralkyl-aether, diphenyle und benzophenone, verfahren zu ihrer herstellung und ihre verwendung |
| JPS509785A (es) * | 1973-05-31 | 1975-01-31 | ||
| JPS5922697B2 (ja) * | 1976-01-13 | 1984-05-28 | エーザイ株式会社 | ビス−（メタ−アミジノフエノキシ）−化合物 |
| DE3066406D1 (en) | 1979-09-13 | 1984-03-08 | Wellcome Found | Diaryl compounds and pharmaceutical formulations containing them |
| US4531009A (en) * | 1982-01-29 | 1985-07-23 | Toray Industries, Inc. | Process for preparing α,ω-bis(2-chlorophenoxy)alkane-4,4'-dicarboxylic acid or its lower alkyl ester |
| US4851423A (en) * | 1986-12-10 | 1989-07-25 | Schering Corporation | Pharmaceutically active compounds |
| JPH0621083B2 (ja) * | 1986-12-22 | 1994-03-23 | 株式会社三光開発科学研究所 | ジ（アリ−ルオキシ）アルカンの製造方法 |
| US4891449A (en) * | 1988-06-30 | 1990-01-02 | Great Lakes Chemical Corporation | Halogenated unsymmetrical higher alkyl phenoxy alkanes |
| KR920701167A (ko) * | 1989-07-07 | 1992-08-11 | 에릭 에스. 딕커 | 약제학적 활성 화합물 |
| JP2625258B2 (ja) * | 1991-06-19 | 1997-07-02 | シェリング・コーポレーション | 経口活性抗ウィルス化合物 |
-
1992
- 1992-06-17 JP JP5501035A patent/JP2625258B2/ja not_active Expired - Lifetime
- 1992-06-17 PL PL92301825A patent/PL169699B1/pl unknown
- 1992-06-17 SK SK1442-93A patent/SK144293A3/sk unknown
- 1992-06-17 TW TW081104731A patent/TW260658B/zh active
- 1992-06-17 AT AT92913416T patent/ATE182874T1/de active
- 1992-06-17 US US08/167,812 patent/US5559133A/en not_active Expired - Lifetime
- 1992-06-17 AU AU22213/92A patent/AU674657B2/en not_active Ceased
- 1992-06-17 CZ CS932797A patent/CZ279793A3/cs unknown
- 1992-06-17 MY MYPI92001031A patent/MY107993A/en unknown
- 1992-06-17 EP EP92305551A patent/EP0519702A1/en active Pending
- 1992-06-17 CA CA002111854A patent/CA2111854C/en not_active Expired - Lifetime
- 1992-06-17 EP EP92913416A patent/EP0590026B1/en not_active Expired - Lifetime
- 1992-06-17 DE DE69229733T patent/DE69229733T2/de not_active Expired - Lifetime
- 1992-06-17 KR KR1019930703932A patent/KR960004887B1/ko not_active IP Right Cessation
- 1992-06-17 WO PCT/US1992/004961 patent/WO1992022520A1/en active IP Right Grant
- 1992-06-17 IL IL102241A patent/IL102241A0/xx unknown
- 1992-06-17 ZA ZA924445A patent/ZA924445B/xx unknown
- 1992-06-17 NZ NZ243180A patent/NZ243180A/en unknown
- 1992-06-17 ES ES92913416T patent/ES2134808T3/es not_active Expired - Lifetime
- 1992-06-17 YU YU63392A patent/YU63392A/sh unknown
- 1992-06-19 MX MX9203068A patent/MX9203068A/es active IP Right Grant
- 1992-07-01 IE IE197192A patent/IE921971A1/en not_active Application Discontinuation
-
1993
- 1993-03-26 US US08/039,532 patent/US5350772A/en not_active Expired - Lifetime
- 1993-12-17 FI FI935690A patent/FI935690A/fi not_active Application Discontinuation
- 1993-12-17 OA OA60450A patent/OA09828A/en unknown
-
1994
- 1994-08-08 US US08/287,325 patent/US5449782A/en not_active Expired - Lifetime
-
1995
- 1995-05-19 US US08/444,583 patent/US5618849A/en not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| AU2221392A (en) | 1993-01-12 |
| WO1992022520A1 (en) | 1992-12-23 |
| JP2625258B2 (ja) | 1997-07-02 |
| US5449782A (en) | 1995-09-12 |
| FI935690A0 (fi) | 1993-12-17 |
| ES2134808T3 (es) | 1999-10-16 |
| YU63392A (sh) | 1994-11-15 |
| US5618849A (en) | 1997-04-08 |
| US5559133A (en) | 1996-09-24 |
| JPH06503839A (ja) | 1994-04-28 |
| EP0590026A1 (en) | 1994-04-06 |
| DE69229733D1 (de) | 1999-09-09 |
| EP0590026B1 (en) | 1999-08-04 |
| NZ243180A (en) | 1995-08-28 |
| OA09828A (en) | 1994-04-15 |
| PL169699B1 (en) | 1996-08-30 |
| IE921971A1 (en) | 1992-12-30 |
| AU674657B2 (en) | 1997-01-09 |
| US5350772A (en) | 1994-09-27 |
| ZA924445B (en) | 1993-02-24 |
| FI935690A (fi) | 1993-12-17 |
| EP0519702A1 (en) | 1992-12-23 |
| CA2111854C (en) | 2001-01-09 |
| CZ279793A3 (en) | 1994-05-18 |
| KR960004887B1 (ko) | 1996-04-16 |
| TW260658B (es) | 1995-10-21 |
| DE69229733T2 (de) | 1999-12-02 |
| IL102241A0 (en) | 1993-01-14 |
| CA2111854A1 (en) | 1992-12-23 |
| ATE182874T1 (de) | 1999-08-15 |
| MX9203068A (es) | 1993-07-01 |
| MY107993A (en) | 1996-07-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE69403823T2 (de) | Substituierte Phenylsulfonamine als selektive B3-Agonisten zur Behandlung von Diabetes und Fettleibigkeit | |
| DE69522676T2 (de) | Naphtalen-derivate als prostaglandin i2 agonisten | |
| DE69215965T2 (de) | Pyrazolopyridinverbindungen und Verfahren zu ihrer Herstellung | |
| LU85856A1 (fr) | Composes de phenethanolamine | |
| EP0181793A1 (fr) | Dérivés de pipéridine, leur préparation et leur application en thérapeutique | |
| FR2567510A1 (fr) | Composes d'aminophenol et compositions pharmaceutiques les contenant | |
| AU2002331145B2 (en) | Prime ring substituted thyroid receptor antagonists for the treatment of cardiac and metabolic disorders | |
| KR100281867B1 (ko) | 3-(비스-치환페닐메틸렌)옥신돌유도체 | |
| WO2019105234A1 (zh) | 芳香族化合物及其药物组合物和用途 | |
| DK158460B (da) | Analogifremgangsmaade til fremstilling af substituerede oxocarboxylsyrer | |
| SK144293A3 (en) | Orally active antiviral compounds | |
| DE69226703T2 (de) | Imidazo (4,5-c)pyridinderivate als paf antagonisten | |
| DE69110217T2 (de) | Derivate der Kaffeinsäure und sie enthaltende pharmazeutische Zusammensetzungen. | |
| ITMI20111463A1 (it) | 1,4-diaril-2-azetidinoni ad attivita' antitumorale | |
| DE3784913T2 (de) | Eicosattraynsaeureamide, ihre verwendung in der arzneimittelkunde und kosmetika, ihre herstellung und verfahren zur herstellung von eicosattraynsaeure. | |
| WO2006088080A1 (ja) | シクロヘプタ［ｂ］ピリジン－３－カルボニルグアニジン誘導体およびそれを含有する医薬品 | |
| JPH01104064A (ja) | 塩基性に置換されたベンゾフランカルボン酸アミド、この化合物の製法及びこれを含有する医薬 | |
| DD157796A5 (de) | Verfahren zur herstellung neuer derivate des 2-amino-aethanols | |
| DE19836406A1 (de) | N-Substituierte Azabicycloheptan-Derivate, ihre Herstellung und Verwendung | |
| SI9400221A (en) | Orally active antipicornaviral compounds | |
| DE2339862A1 (de) | Neue substituierte phenylessigsaeureester und verfahren zu ihrer herstellung | |
| NZ270131A (en) | Orally active antiviral aromatic ether compounds | |
| HRP920365A2 (en) | Bis(oxy) compounds and process for their preparation | |
| JPH0358985A (ja) | ホモピペラジン誘導体及びこれを含有する脳保護剤 | |
| SI9200271A (sl) | Substituirani derivati karboksilnih kislin |